Arm width and brightness modulation of spontaneous behaviour of two strains of mice tested in the elevated plus-maze

Physiology and Behavior

Volumn 59, Issue 3, 1996, Pages 439-444

  Lamberty, Yves ^a,b   Gower, Alma J ^b,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UCB PHARMA   (Belgium)

^c Pharmaco LSR   (United Kingdom)

Author keywords

Anxiety; Arm brightness; Arm width; Elevated plus maze; Mice; Strain differences

Indexed keywords

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; BRIGHTNESS; CONTROLLED STUDY; MALE; MAZE TEST; MOBILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0029911766     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/0031-9384(96)84912-2     Document Type: Article

References (41)

1. Archer, J. Tests for emotionality in rats and mice: A review. Anim. Behav. 21:205-235; 1975.
2. Armario, A.; Montero, J. L.; Balasch, J. Sensitivity of corticosterone and some metabolic variables to graded levels of low intensity stresses in adult male rats. Physiol. Behav. 37:559-561; 1986.
3. Armario, A.; Marti, J.; Gil, M. The serum glucose response to acute stress is sensitive to the intensity of the stressor and to habituation. Psychoneuroendocrinology 15:341-347; 1990.
4. Blanchard, D. C.; Blanchard, R. J.; Rodgers, R. J. Risk assessment and animal models of anxiety. In: Animal models in psychopharmacology. Advances in pharmacological sciences. Basel: Birkauser Verlag; 1991:117-134.
5. Brioni, J. D.; O' Neill, A. B.; Kim, D. J. B.; Decker, M. W. Nicotinic receptor agonists exhibit anxiolytic-like effects in the elevated plus-maze test. Eur. J. Pharmacol. 238:1-8; 1993.
6. Chopin, P.; Briley, M. Animal models of anxiety: The effects of compounds that modify 5-HT neurotransmission. Trends Pharmacol. Sci. 8:383-388; 1987.
7. 2 receptors. Psychopharmacology (Berlin) 93:502-506; 1987.
8. De Angelis, L. The nootropic drugs piracetam and oxiracetam do not reduce anxiety in mice during elevated-X-maze testing. Curr. Ther. Res. 52:230-237, 1992.
9. Everill, B.; Brain, P. F.; Rustana, A.; Mos, J.; Olivier, B. Ethoexperimental analysis of the impact of chlordiazepoxide on social interactions in three strains of mice. Behav. Processes 25:55-67; 1991.
10. Falter, U.; Gower, A. J.; Gobert, J. Resistance of baseline activity in the elevated plus-maze to exogenous influences. Behav. Pharmacol. 3:123-128; 1992.
11. File, S. E. Behavioural detection of anxiolytic action. In: Elliott, J. M.; Heal, D. J.; Mardsen, C. A., ed. Experimental approaches to anxiety and depression. New York: John Wiley; 1992:25-44.
12. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology (Berlin) 99:248-251; 1989.
13. Gentsch, C.; Lichtsteiner, M.; Feer, H. Open field and elevated plus-maze: A behavioural comparison between hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide. Behav. Brain Res. 25:101-107; 1987.
14. Griebel, G.; Moreau, J. L.; Jenck, F.; Martin, J. R.; Misslin, R. Some critical determinants of the behaviour of rats in the elevated plus-maze. Behav. Processes 29:37-48; 1993.
15. Gyertyan, I. Animal models of anxiety: A critical review. Acta Physiol. Hung. 79:369-379; 1992.
16. Imhof, J. T.; Coelho, Z. M. I.; Schmitt, M. L.; Morato, G. S.; Carobrez, A. P. Influence of gender and age on performance of rats in the elevated plus maze apparatus. Behav. Brain Res. 56:177-180; 1993.
17. Ishihara, S.; Hiramatsu, M.; Kameyama, T.; Nabeshima, T. Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAa receptors. J. Neural Transm. 91:27-37; 1993.
18. Itoh, J.; Nabeshima, T.; Kameyama, T. Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology (Berlin) 101:27-33; 1990.
19. Johnston, A. L.; File, S. A. Sex differences in animal tests of anxiety. Physiol. Behav. 49:245-250; 1991.
20. Kostowski, W.; Plasnik, A.; Stefanski, R. Intra-hippocampal buspirone in animal models of anxiety. Eur. J. Pharmacol. 168:393-396; 1989.
21. Kulkarni, S. K.; Sharma, A. C. Elevated plus-maze: A novel psychobehavioral tool to measure anxiety in rodents. Methods Find. Exp. Clin. Pharmacol. 13:573-577; 1991.
22. Lamberty, Y.; Gower, A. J. Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age. Physiol. Behav. 47:1137-1144; 1990.
23. Lamberty, Y.; Gower, A. J. Age-related changes in spontaneous behaviour and learning in NMRI mice from middle to old age. Physiol. Behav. 51:81-88; 1992.
24. Lapin, I. P. Anxiogenic effects of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol. Pharmacol. Bioch. Behav. 44:241-243; 1993.
25. Lister, R. G. The use of a plus maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92:180-185; 1987.
26. Lister, R. G. Ethologically based animal models of anxiety disorders. Pharmac. Ther. 46:321-340; 1990.
27. Mc Blane, J. W.; Critchley, M. A. E.; Handley, S. L. Light intensity influences the response to 8-OH-DPAT in the elevated X-maze model of anxiety. Br. J. Pharmacol. 105(Suppl.):221P; 1992.
28. Meddis, R. Statistics using ranks: A unified approach. Oxford: Basil Blackwell; 1984.
29. Montgomery, K. C. The relation between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:254-260; 1955.
30. Morato, S.; Castrechini, P. Effects of floor surface and environmental illumination on exploratory activity in the elevated plus-maze. Braz. J. Med. Biol. Res. 22:707-710; 1989.
31. Moser, P. C. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology (Berlin) 99:48-53; 1989.
32. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
33. Rodgers, R. J.; Cole, J. C.; Cobain, M. R.; et al. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: Profile comparison with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav. Pharmacol. 3:621-634; 1992.
34. Sanger, D. J. Animal models of anxiety and the screening and development of novel anxiolytic drugs. In: Boulton, A.; Baker, G.; Martin-Iverson, M., eds. Animal models in psychiatry, II. Clifton: Humana Press; 1991:147-198.
35. Steenbergen, H. L.; Farabollini, F.; Heinsbroek, R. P. W.; Van de Poll, N. E. Sex-dependent effects of aversive stimulation on the holeboard and elevated plus-maze behavior. Behav. Brain Res. 43:159-165; 1991.
36. Siegel, S.; Castellan, N. J. Nonparametric statistics for the behavioral sciences. New York: Mc Graw-Hill; 1988.
37. Taukulis, H. K.; Mc Kay, R. W. Post drug retention of diazepam's effects on habituation to a novel environment in an animal model of anxiety. Psychobiology 20:286-293; 1992.
38. Treit, D.; Menard, J.; Royan, C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Bioch. Behav. 44:463-469; 1993.
39. Trullas, R.; Skolnick, P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology (Berlin) 111:323-331; 1993.
40. Trullas, R.; Folio, T.; Young, A.; Miller, R.; Boje, K.; Skolnick, P. 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur. J. Pharmacol. 203:379-385; 1991.
41. Zimmerberg, B.; Farley, M. J. Sex-differences in anxiety behavior in rats: Role of gonadal hormones. Physiol. Behav. 54:1119-1124; 1993.